Data & Technology

Electronic health record messaging network found to improve communication and lead to better medication adherence.

Provider’s Pithampur facility is recognized for its use of Industry 4.0 technology.

How pharma companies can be successful in financial forecasting, including why these forecasts should be powered by a patient-based approach.

Popular works in the category explore 340B guidelines, ‘smart pharma’ capabilities, and commercialization trends.

This year’s PC Podcast episodes ranged in topic, from DSCSA compliance to pharmacovigilance.

A panel designs a conceptual framework in an effort to limit partiality.

Cloud-based service to address verification of saleable returns under the latest DSCSA regulations.

Creating a meaningful digital transformation requires pharmaceutical manufacturing companies to incorporate the right technologies, processes, and systems to reach their fullest potential.

Critical factors need to be addressed for pharma stakeholders to realize the full potential of generative artificial intelligence.

Digital twins allow the industry to integrate sustainable practices and supply chain efficiency solutions while ensuring patient safety.

Findings suggest that participants nationwide who were offered and accessed their online medical record has more than doubled in the past eight years, but racial and ethnic disparities continue.

Study estimates that up to 20% of the costs for clinical research is associated with the manual transfer and verification of data from the electronic medical record to a data capture system.

New initiative highlights importance of a collaborative approach that allows patients to share their insights and contribute value to studies.

Stephanie L. Woerner, PhD, director and principal research scientist at the MIT Center for Information Systems Research, discusses the outlook for next year among biopharma firms.

A demand-driven methodology for data standardization across multiple streams of acquisition could improve the sharing of real-world data worldwide.

New E2E workflow orchestration service is expected to simplify the processes of health systems and retail pharmacies while also reducing the risk of recalled items reaching patients.

Financial commitment further strengthens IntegriChain’s platform as a source for pharma manufacturers' commercialization and market access goals.

Session explains how to use this information to help bolster market intelligence, market access, and affordability strategies.

Studies with Zenith-CKD showed significant albuminuria reduction.

There are a slew of specialist and boutique companies set up to provide high quality services and to meet the changing needs of the pharma industry.

With new tech acquisition, the software company also introduces a new branded AI assistant for mobile devices specifically for the life sciences sector.

Exagamglogene autotemcel (exa-cel) has shown the potential to be a landmark therapy in preventing episodes of excruciating pain among patients with sickle cell disease.

How drugmakers can better harness real-world evidence to drive their clinical and commercial objectives, while also providing greater clarity for healthcare providers and improved access to therapy for the patients they serve.

A breakdown on the decision, and how to navigate these obstacles using a network approach.

Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.

Panel discusses how digital transformation can best impact supply chains.

A look into ways to approach change management using three factors.

A panel at the recent Talk Health event in Philadelphia focused on what success looks like in audio from publisher, vendor, and HCP perspectives.

Alexion – AstraZeneca Rare Disease, GSK, Novartis, Pfrizer, and Zoetis will join the newly established life sciences platform.